Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats

Abstract

Cardiovascular and metabolic adjustments during stress involve participation of the sympatho-adrenal and hypothalamic-pituitary-adrenocortical systems, which interact at several levels. The present study investigated the effects of removal of endogenous glucocorticoids on indices of norepinephrine release and metabolism and of catecholamine biosynthesis in sympathetic nerves, at baseline and in response to immobilization stress (IMMO) in rats. Plasma levels of the catecholamine precursor dihydroxyphenylalanine, norepinephrine (NE), the NE metabolites dihydroxyphenylglycol and methoxyhydroxyphenylglycol, dopamine, and the dopamine metabolites dihydroxyphenylacetic acid and homovanillic acid were measured in adrenalectomized, adrenal-medullectomized, or sham-operated conscious rats, with or without glucocorticoid treatment (25 mg/kg.24 h cortisol for 7 days by osmotic minipumps), at rest and after 5, 20, 60, and 120 min of IMMO. Adrenalectomy eliminated plasma levels of epinephrine and corticosterone and augmented IMMO-induced increments in levels of NE, dihydroxyphenylglycol, methoxyhydroxyphenylglycol, dihydroxyphenylalanine, dihydroxyphenylacetic acid, and homovanillic acid. Adrenal-medullectomy reduced plasma epinephrine, but not corticosterone, to undetectable levels at baseline and did not augment stress-induced responses of any of the measured compounds. Cortisol administration (plasma levels approximately 600 pmol/ml) reversed the augmentation of catecholaminergic responses in adrenalectomized rats. The results indicate that adrenalectomy stimulates several aspects of sympatho-neural function, including stress-induced increments in NE release, reuptake, metabolism, and turnover and in catecholamine biosynthesis. This augmentation was absent in adreno-medullectomized rats, indicating that the loss of adrenomedullary hormones after adrenalectomy does not appear to contribute to the augmentation. Since cortisol treatment reversed or prevented this augmentation, loss of feedback inhibition by endogenous glucocorticoids appears to be the basis of the enhanced responses. Thus, the results suggest that endogenous glucocorticoids restrain responses of catecholamine turnover, synthesis, release, reuptake, and metabolism in sympathetic nerves in this stress model.

Stress-induced enhancement of skin immune function: A role for γ interferon

“…Restraint stress is thought to be largely psychological in nature, resulting from the perception of confinement on part of the animal (24,25). Restraint activates the autonomic nervous system (26) and the hypothalamic-pituitary-adrenal axis (27,28) and results in the activation of adrenal steroid receptors in tissues throughout the body (28).…”

Repeated 2-deoxy-D-glucose-induced glucoprivation attenuates Fos expression and glucoregulatory responses during subsequent glucoprivation.

“…In addition, it has been shown that chronic reduction of glucocorticoid levels increases basal and stress-induced activity of hindbrain catecholaminergic neurons (38,39) and increases catecholamine release in the PVH (40,41). Chronic elevation of glucocorticoid levels decreases basal catecholamine levels and reduces stress-induced catecholamine release, metabolism, turnover, and synthesis in the PVH (42).…”

Diabetes Impairs Hypothalamo-Pituitary-Adrenal (HPA) Responses to Hypoglycemia, and Insulin Treatment Normalizes HPA but not Epinephrine Responses

“…However, in situations of impaired or deficient glucagon secretion, such as type 1 diabetes, epinephrine and, more chronically, cortisol begin to play a very important role in the recovery from hypoglycemia (3). As such, regulation of the hypothalamopituitary-adrenal (HPA) axis is an important factor in the pathology of defective counterregulatory mechanisms in diabetes, since the HPA axis not only regulates glucocorticoid secretion but can also affect epinephrine secretion (4). The important roles of glucocorticoids in glucoregulation are the regulation of liver sensitivity to glucagon and epinephrine and reduction of hepatic and peripheral insulin sensitivity (5).…”